表紙
市場調查報告書
商品編碼
977807

全球體外診斷用酵素的市場趨勢·市場佔有率·市場規模的預測 (2020-2027年): 酵素類型 (聚合酵素&轉印酵素·蛋白分解酵素)·疾病區分·技術·終端用戶·各地區

In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2020 - 2027

出版日期: | 出版商: Grand View Research, Inc. | 英文 199 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球體外診斷用酵素的市場規模在預測期間內預計將以8.97%的年複合成長率推移,並成長到2027年14億1000萬美元的規模。正確迅速的診斷和治療對於優化臨床結果至關重要。由於其出色的生物催化性能,酶可用於各種疾病的診斷。

本報告提供全球體外診斷用酵素的市場調查,彙整市場及產品概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,酵素類型·治療領域·技術·終端用戶·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 市場趨勢·展望
  • 市場分類·範圍
  • 市場預測
  • 價格分析
  • COVID-19的影響
  • 商業環境分析
  • 普及·成長預測製圖

第4章 市場動態

  • 市場成長的促進因素
  • 市場阻礙成長要素
  • 市場機會
  • 市場課題

第5章 市場預測·趨勢分析:各酵素類型

  • 蛋白分解酵素
  • 聚合酶/轉錄酶
  • 核糖核酸酶
  • 其他

第6章 市場預測·趨勢分析:各治療領域

  • 感染疾病
    • COVID-19檢驗
    • 肝炎
    • HIV
    • 其他
  • 糖尿病
  • 腫瘤
  • 心臟病
  • 腎臟
  • 自體免疫疾病
  • 其他

第7章 市場預測·趨勢分析:各技術類型

  • 組織學化驗
  • 分子診斷
    • PCR化驗
    • NGS化驗
    • 其他
  • 臨床化學

第8章 市場預測·趨勢分析:各終端用戶

  • 醫藥品·生物醫藥品企業
  • 醫院·診斷實驗室
  • CRO
  • 學術實驗室

第9章 市場預測·趨勢分析:各地區·主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 南美
    • 巴西
    • 墨西哥
  • 中東·非洲
    • 南非

第10章 競爭情形

  • 策略性架構
  • 進入經營者的分類
  • 企業簡介
    • Merck KGaA
    • Codexis
    • F. Hoffmann-La Roche Ltd.
    • Amano Enzymes
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Amicogen
    • Dyadic International
    • BBI Solutions
    • Affymetrix
    • American Laboratories
目錄
Product Code: GVR-4-68039-246-6

In-vitro Diagnostics Enzymes Market Growth & Trends:

The global in-vitro diagnostics enzymes market size is expected to reach USD 1.41 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.97% from 2020 to 2027. Accurate and rapid diagnosis and treatment of clinical disorders are essential for optimal clinical outcomes. Owing to the noteworthy biocatalytic properties, enzymes are used in the diagnosis of a wide range of diseases.

The development of enzyme biosensors has increased the enzyme utility in clinical diagnostics. Despite the necessity in clinical diagnosis, the commercialization and translation of biosensors from research to clinics are still low. However, with an increase in R&D efforts, lactate, cholesterol, and glucose biosensors have been commercialized for diagnostic use.

Proteases are important signaling proteins that are critical to a few pathological processes, including cancer, neurological, inflammatory, and cardiovascular disorders. Polymerase and transcriptase enzymes are expected to exhibit the fastest CAGR over the forecast period. In addition, the presence of a substantial number of players that offer these enzymes is expected to enhance the growth. Key players such as Kaneka Eurogentec S.A.; Toyobo Co., Ltd.; and Sekisui Diagnostics, LLC manufacture and distribute a wide range of polymerases, including KOD DNA Polymerase, Taq DNA Polymerase, Tth DNA Polymerase, and TTx DNA Polymerase.

The infectious disease segment dominated the market in 2019. An exponential rise in the COVID-19 cases globally drives the adoption rate of diagnostic enzymes for COVID-19 diagnosis. An increase in the availability of qualitative and quantitative molecular assays based on real-time PCR, Loop-mediated Isothermal Amplification- PCR (LAMP-PCR), multiplex PCR, and digital PCR technologies for the diagnosis of infectious diseases drives the demand for enzymes in this segment.

Enzymatic immunohistochemistry (IHC) is preferred for histology owing to a better contrast ratio and the method's compatibility for use with multiple stains for the detection of target components. IVD enzymes are employed in different end-use settings for the analysis of tissue specimens and bodily fluids. A wide range of end users including large laboratories that conduct multiple analyses in a day and smaller clinics that conduct a few tests use enzymes for in-vitro diagnostics (IVD).

North America emerged as a prominent regional market in 2019. A rise in the number of cancer cases and the adoption of enzymes for histopathology of biopsy samples are some of the other factors expected to propel market growth in the region. The presence of a large target population, improvements in healthcare infrastructure, high unmet clinical needs, increase in government initiatives, and rise in R&D activities for advanced diagnostic techniques are anticipated to drive the Asia Pacific market with the fastest growth rate.

The key players in the market are involved in novel product launches, acquisitions, collaborations, partnerships, and geographical expansions to reinforce their market presence. For instance, in June 2020, Codexis, Inc. signed a collaboration agreement with Alphazyme LLC for the manufacture and co-marketing of high-fidelity DNA polymerase, T7 RNA polymerase, and reverse transcriptase.

In-vitro Diagnostics Enzymes Market Report Highlights:

  • By enzyme type, polymerase and transcriptase enzymes held the largest share in 2019 owing to their wide applications in molecular diagnostic assays
  • Based on disease type, the infectious disease segment is expected to dominate the market throughout the forecast period
  • In terms of technology type, the histology assays segment held the largest share in 2019 owing to the utility of histology assays in cancer diagnostics, coupled with a rising incidence of different cancer types
  • By end use, hospital and diagnostic labs dominated the market in 2019. They witness a high inflow of biopsy specimens for histopathology and cytopathology because of an increase in hospitalization and rise in the number of hospital admissions for cancer patients
  • North America dominated the overall market in 2019 owing to the presence of a substantial number of players in this region including Innovative Research; Bio-Rad Laboratories, Inc.; Rockland Immunochemicals, Inc.; MyBioSource.com; and RayBiotech, Inc.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Model
    • 1.3.1 Parent market Study
      • 1.3.1.1 Global enzymes market
      • 1.3.1.2 Global IVD market
      • 1.3.1.3 Market study, by region
  • 1.4 Objectives
    • 1.4.1 Objective 1:
    • 1.4.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends and Outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Market Lineage Outlook
    • 3.3.1 Parent Market Analysis
      • 3.3.1.1 IVD MARKET
      • 3.3.1.2 MOLECULAR BIOLOGY ENZYMES AND KITS MARKET
  • 3.4 Pricing Analysis
    • 3.4.1 Pricing for Proteases: Bulk Orders
    • 3.4.2 Pricing for Proteases: General Orders
    • 3.4.3 Pricing for IVD Grade Proteases: General Orders
  • 3.5 Impact of COVID-19
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
    • 3.6.2 Porter's Five Forces Analysis
  • 3.7 Penetration and Growth Prospect Mapping for technology type, 2019 (USD Million)

Chapter 4 Market Dynamics

  • 4.1 Market driver analysis
    • 4.1.1 Rise in demand for enzyme biosensors for point of care testing
    • 4.1.2 Wide applications of enzymes in pathology
    • 4.1.3 Advancements in diagnostic testing of viral infections
  • 4.2 Market Restraint Analysis
    • 4.2.1 Regulatory & reimbursement hurdles for in-vitro diagnostics
    • 4.2.2 High cost of enzyme-based diagnostic test
  • 4.3 Market Opportunity Analysis
    • 4.3.1 Advances in Molecular Diagnostics Technologies
  • 4.4 Market Challenge Analysis
    • 4.4.1 Challenges associated with clinical chemistry testing

Chapter 5 IVD Enzymes Market: Enzyme Type Estimates & Trend Analysis

  • 5.1 Segment Definition
  • 5.2 Market Formulation and Modelling
  • 5.3 IVD Enzymes Market: Enzyme Type Movement Analysis
  • 5.4 Proteases
    • 5.4.1 IVD proteases market, 2016 - 2027 (USD Million)
    • 5.4.2 By Therapeutic Area
      • 5.4.2.1 Segment Definition
      • 5.4.2.2 Infectious diseases
      • 5.4.2.2.1 IVD proteases market for infectious diseases, 2016 - 2027 (USD Million)
      • 5.4.2.3 Diabetes
      • 5.4.2.3.1 IVD proteases market for diabetes, 2016 - 2027 (USD Million)
      • 5.4.2.4 Oncology
      • 5.4.2.4.1 IVD proteases market for oncology, 2016 - 2027 (USD Million)
      • 5.4.2.5 Cardiology
      • 5.4.2.5.1 IVD proteases market for cardiology, 2016 - 2027 (USD Million)
      • 5.4.2.6 Nephrology
      • 5.4.2.6.1 IVD proteases market for nephrology, 2016 - 2027 (USD Million)
      • 5.4.2.7 Autoimmune Diseases
      • 5.4.2.7.1 IVD proteases market for autoimmune diseases, 2016 - 2027 (USD Million)
      • 5.4.2.8 Others
      • 5.4.2.8.1 IVD proteases market for other diseases, 2016 - 2027 (USD Million)
    • 5.4.3 By Technology type Use
      • 5.4.3.1 Segment Definition
      • 5.4.3.2 Histology Assays
      • 5.4.3.2.1 IVD proteases market for histology assays, 2016 - 2027 (USD Million)
      • 5.4.3.3 Molecular Diagnostics
      • 5.4.3.3.1 IVD proteases market for molecular diagnostics, 2016 - 2027 (USD Million)
      • 5.4.3.3.2 PCR Assays
      • 5.4.3.3.2.1 IVD proteases market for PCR assays, 2016 - 2027 (USD Million)
      • 5.4.3.3.3 NGS Assays
      • 5.4.3.3.3.1 IVD proteases market for NGS assays, 2016 - 2027 (USD Million)
      • 5.4.3.3.4 Others
      • 5.4.3.3.4.1 IVD proteases market for other assays, 2016 - 2027 (USD Million)
      • 5.4.3.4 Clinical chemistry
      • 5.4.3.4.1 IVD proteases market for clinical chemistry, 2016 - 2027 (USD Million)
    • 5.4.4 By Physical Form
      • 5.4.4.1 Segment Definition
      • 5.4.4.2 Powder
      • 5.4.4.2.1 Powder IVD proteases market, 2016 - 2027 (USD Million)
      • 5.4.4.3 Liquid
      • 5.4.4.3.1 Liquid IVD proteases market, 2016 - 2027 (USD Million)
    • 5.4.5 By Type
      • 5.4.5.1 Segment Definition
      • 5.4.5.2 Natural
      • 5.4.5.2.1 Natural IVD proteases market, 2016 - 2027 (USD Million)
      • 5.4.5.3 Recombinant
      • 5.4.5.3.1 Recombinant IVD proteases market, 2016 - 2027 (USD Million)
    • 5.4.6 By End Use
      • 5.4.6.1 Segment Definition
      • 5.4.6.2 Pharma & Biotech
      • 5.4.6.2.1 IVD proteases market for pharma & biotech companies, 2016 - 2027 (USD Million)
      • 5.4.6.3 Hospital & Diagnostic Labs
      • 5.4.6.3.1 IVD proteases market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
      • 5.4.6.4 CROs
      • 5.4.6.4.1 IVD proteases market for CROs, 2016 - 2027 (USD Million)
      • 5.4.6.5 Academic labs
      • 5.4.6.5.1 IVD proteases market for academic labs, 2016 - 2027 (USD Million)
  • 5.5 Polymerase & Transcriptase
    • 5.5.1 IVD polymerase & transcriptase market, 2016 - 2027 (USD Million)
  • 5.6 Ribonuclease
    • 5.6.1 IVD ribonuclease market, 2016 - 2027 (USD Million)
  • 5.7 Others
    • 5.7.1 Other IVD enzymes market, 2016 - 2027 (USD Million)

Chapter 6 IVD Enzymes Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1 Segment Definition
  • 6.2 Market Formulation and Modelling
  • 6.3 IVD Enzymes Market: Therapeutic Area Movement Analysis
  • 6.4 Infectious Disease
    • 6.4.1 IVD enzymes market for infectious disease, 2016 - 2027 (USD Million)
    • 6.4.2 COVID-19 Testing
      • 6.4.2.1 IVD enzymes market for COVID-19 testing, 2016 - 2027 (USD Million)
    • 6.4.3 Hepatitis
      • 6.4.3.1 IVD enzymes market for hepatitis, 2016 - 2027 (USD Million)
    • 6.4.4 HIV
      • 6.4.4.1 IVD enzymes market for HIV, 2016 - 2027 (USD Million)
    • 6.4.5 Other infectious diseases
      • 6.4.5.1 IVD enzymes market for other infectious diseases, 2016 - 2027 (USD Million)
  • 6.5 Diabetes
    • 6.5.1 IVD enzymes market for diabetes, 2016 - 2027 (USD Million)
  • 6.6 Oncology
    • 6.6.1 IVD enzymes market for oncology, 2016 - 2027 (USD Million)
  • 6.7 Cardiology
    • 6.7.1 IVD enzymes market for cardiology, 2016 - 2027 (USD Million)
  • 6.8 Nephrology
    • 6.8.1 IVD enzymes market for nephrology, 2016 - 2027 (USD Million)
  • 6.9 Autoimmune Diseases
    • 6.9.1 IVD enzymes market for autoimmune diseases, 2016 - 2027 (USD Million)
  • 6.10 Others
    • 6.10.1 IVD enzymes market for other diseases, 2016 - 2027 (USD Million)

Chapter 7 IVD Enzymes Market: Technology Type Estimates & Trend Analysis

  • 7.1 Segment Definition
  • 7.2 Market Formulation and Modelling
  • 7.3 IVD Enzymes Market: Technology Type Movement Analysis
  • 7.4 Histology Assays
    • 7.4.1 IVD enzymes market for histology assays, 2016 - 2027 (USD Million)
  • 7.5 Molecular Diagnostics
    • 7.5.1 IVD enzymes market for molecular diagnostics, 2016 - 2027 (USD Million)
    • 7.5.2 PCR Assays
      • 7.5.2.1 IVD enzymes market for PCR assays, 2016 - 2027 (USD Million)
    • 7.5.3 NGS Assays
      • 7.5.3.1 IVD enzymes market for NGS assays, 2016 - 2027 (USD Million)
    • 7.5.4 Others
      • 7.5.4.1 IVD enzymes market for other molecular biology assays, 2016 - 2027 (USD Million)
  • 7.6 Clinical Chemistry
    • 7.6.1 IVD enzymes market for clinical chemistry, 2016 - 2027 (USD Million)

Chapter 8 IVD Enzymes Market: End-use Estimates & Trend Analysis

  • 8.1 Segment Definition
  • 8.2 Market Formulation and Modelling
  • 8.3 IVD Enzymes Market: End-use Movement Analysis
  • 8.4 Pharma & Biotech
    • 8.4.1 IVD enzymes market for pharma & biotech, 2016 - 2027 (USD Million)
  • 8.5 Hospital & Diagnostic Labs
    • 8.5.1 IVD enzymes market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
  • 8.6 CROs
    • 8.6.1 IVD enzymes market for CROs, 2016 - 2027 (USD Million)
  • 8.7 Academic Labs
    • 8.7.1 IVD enzymes market for academic labs, 2016 - 2027 (USD Million)

Chapter 9 IVD Enzymes Market: Regional Estimates & Trend Analysis

  • 9.1 IVD Enzymes Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America IVD enzymes market estimates and forecast, 2016-2027 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.2.2.2 U.S. IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.2.2.3 U.S. IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.2.2.4 U.S. IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.2.2.5 U.S. IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.2.3.2 Canada IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.2.3.3 Canada IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.2.3.4 Canada IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.2.3.5 Canada IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.3.2.2 Germany IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.3.2.3 Germany IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.3.2.4 Germany IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.3.2.5 Germany IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.3.3 France
      • 9.3.3.1 France IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.3.3.2 France IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.3.3.3 France IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.3.3.4 France IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.3.3.5 France IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.3.4 U.K.
      • 9.3.4.1 U.K. IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.3.4.2 U.K. IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.3.4.3 U.K. IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.3.4.4 U.K. IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.3.4.5 U.K. IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.3.5.2 Italy IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.3.5.3 Italy IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.3.5.4 Italy IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.3.5.5 Italy IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.3.6.2 Spain IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.3.6.3 Spain IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.3.6.4 Spain IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.3.6.5 Spain IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.4.2.2 Japan IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.4.2.3 Japan IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.4.2.4 Japan IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.4.2.5 Japan IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.4.3.2 China IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.4.3.3 China IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.4.3.4 China IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.4.3.5 China IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.4.4.2 India IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.4.4.3 India IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.4.4.4 India IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.4.4.5 India IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.5.2.2 Brazil IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.5.2.3 Brazil IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.5.2.4 Brazil IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.5.2.5 Brazil IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.5.3.2 Mexico IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.5.3.3 Mexico IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.5.3.4 Mexico IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.5.3.5 Mexico IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)
  • 9.6 Middle East & Africa (MEA)
    • 9.6.1 MEA IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
      • 9.6.2.2 South Africa IVD enzymes market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
      • 9.6.2.3 South Africa IVD enzymes market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
      • 9.6.2.4 South Africa IVD enzymes market estimates and forecast, by technology type 2016 - 2027 (USD Million)
      • 9.6.2.5 South Africa IVD enzymes market estimates and forecast, by end-use 2016 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Strategy Framework
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 Merck KGaA
      • 10.3.1.1 Company overview
      • 10.3.1.2 Sigma-Aldrich Co. LLC
      • 10.3.1.2.1 Company overview
      • 10.3.1.3 Financial performance
      • 10.3.1.4 Product benchmarking
      • 10.3.1.5 Strategic initiatives
    • 10.3.2 Codexis
      • 10.3.2.1 Company overview
      • 10.3.2.2 Financial performance
      • 10.3.2.3 Product benchmarking
      • 10.3.2.4 Strategic initiatives
    • 10.3.3 F. Hoffmann-La Roche Ltd.
      • 10.3.3.1 Company overview
      • 10.3.3.2 Financial performance
      • 10.3.3.3 Product benchmarking
      • 10.3.3.4 Strategic initiatives
    • 10.3.4 Amano Enzymes
      • 10.3.4.1 Company overview
      • 10.3.4.2 Financial performance
      • 10.3.4.3 Product benchmarking
      • 10.3.4.4 Strategic initiatives
    • 10.3.5 Advanced Enzymes Technologies Ltd.
      • 10.3.5.1 Company overview
      • 10.3.5.2 Financial performance
      • 10.3.5.3 Product benchmarking
      • 10.3.5.4 Strategic initiatives
    • 10.3.6 Biocatalysts Ltd.
      • 10.3.6.1 Company overview
      • 10.3.6.2 Financial performance
      • 10.3.6.3 Product benchmarking
      • 10.3.6.4 Strategic initiatives
    • 10.3.7 Amicogen
      • 10.3.7.1 Company overview
      • 10.3.7.2 Financial performance
      • 10.3.7.3 Product benchmarking
      • 10.3.7.4 Strategic initiatives
    • 10.3.8 Dyadic International
      • 10.3.8.1 Company overview
      • 10.3.8.2 Financial performance
      • 10.3.8.3 Product benchmarking
      • 10.3.8.4 Strategic initiatives
    • 10.3.9 BBI Solutions
      • 10.3.9.1 Company overview
      • 10.3.9.2 Financial performance
      • 10.3.9.3 Product benchmarking
      • 10.3.9.4 Strategic initiatives
    • 10.3.10 Affymetrix
      • 10.3.10.1 Company overview
      • 10.3.10.2 Financial performance
      • 10.3.10.3 Product benchmarking
      • 10.3.10.4 Strategic initiatives
    • 10.3.11 American Laboratories
      • 10.3.11.1 Company overview
      • 10.3.11.2 Financial performance
      • 10.3.11.3 Product benchmarking
      • 10.3.11.4 Strategic initiatives

List of Tables

  • Table 1 Pricing for Acid Proteases: Bulk Orders
  • Table 2 Pricing for Alkaline Proteases: Bulk Orders
  • Table 3 Pricing for Neutral Proteases: Bulk Orders
  • Table 4 Pricing for Proteases from Aspergillus oryzae: General Orders
  • Table 5 Pricing for Proteases from Bacillus amyloliquefaciens: General Orders
  • Table 6 Pricing for Proteases from Bacillus licheniformis: General Orders
  • Table 7 Pricing for Proteases from Bacillus sp: General Orders
  • Table 8 Pricing for Proteases from Streptomyces griseus: General Orders
  • Table 9 Pricing for Proteases from Streptomyces griseus: General Orders
  • Table 10 Pricing for Proteases from Aspergillus melleus: General Orders
  • Table 11 Pricing for IVD grade trypsin from bovine pancreas
  • Table 12 Pricing for IVD grade trypsin from porcine pancreas
  • Table 13 Pricing for IVD grade pepsin from porcine gastric mucosa
  • Table 14 List of molecular tests for COVID-19 diagnosis
  • Table 15 List of antigen diagnostic tests for COVID-19 diagnosis
  • Table 16 List of home-based molecular tests for COVID-19 diagnosis
  • Table 17 Commercial Enzymatic Biosensors for Clinical Applications
  • Table 18 Commercial availability of proteases commonly used for fragmenting proteins
  • Table 19 Enzymes in diagnosis of diseases
  • Table 20 Percentage breakdown of revenue (2019) for infectious disease, by enzyme type
  • Table 21 Percentage breakdown of revenue (2019) for diabetes, by enzyme type
  • Table 22 Percentage breakdown of revenue (2019) for oncology, by enzyme type
  • Table 23 Percentage breakdown of revenue (2019) for cardiology, by enzyme type
  • Table 24 Percentage breakdown of revenue (2019) for nephrology, by enzyme type
  • Table 25 Percentage breakdown of revenue (2019) for autoimmune diseases, by enzyme type
  • Table 26 Percentage breakdown of revenue (2019) for other diseases, by enzyme type
  • Table 27 Clinical chemistry: Key enzymes
  • Table 28 North America IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 29 North America protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 30 North America protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 31 North America molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 32 North America protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 33 North America protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 34 North America protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 35 North America IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 36 North America infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 37 North America IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 38 North America molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 39 North America IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 40 U.S. IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 41 U.S. protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 42 U.S. protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 43 U.S. molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 44 U.S. protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 45 U.S. protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 46 U.S. protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 47 U.S. IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 48 U.S. infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 49 U.S. IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 50 U.S. molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 51 U.S. IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 52 Canada IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 53 Canada protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 54 Canada protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 55 Canada molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 56 Canada protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 57 Canada protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 58 Canada protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 59 Canada IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 60 Canada infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 61 Canada IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 62 Canada molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 63 Canada IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 64 Europe IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 65 Europe protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 66 Europe protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 67 Europe molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 68 Europe protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 69 Europe protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 70 Europe protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 71 Europe IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 72 Europe infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 73 Europe IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 74 Europe molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 75 Europe IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 76 Germany IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 77 Germany protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 78 Germany protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 79 Germany molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 80 Germany protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 81 Germany protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 82 Germany protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 83 Germany IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 84 Germany infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 85 Germany IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 86 Germany molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 87 Germany IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 88 France IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 89 France protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 90 France protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 91 France molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 92 France protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 93 France protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 94 France protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 95 France IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 96 France infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 97 France IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 98 France molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 99 France IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 100 U.K. IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 101 U.K. protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 102 U.K. protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 103 U.K. molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 104 U.K. protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 105 U.K. protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 106 U.K. protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 107 U.K. IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 108 U.K. infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 109 U.K. IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 110 U.K. molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 111 U.K. IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 112 Italy IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 113 Italy protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 114 Italy protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 115 Italy molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 116 Italy protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 117 Italy protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 118 Italy protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 119 Italy IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 120 Italy infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 121 Italy IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 122 Italy molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 123 Italy IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 124 Spain IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 125 Spain protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 126 Spain protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 127 Spain molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 128 Spain protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 129 Spain protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 130 Spain protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 131 Spain IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 132 Spain infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 133 Spain IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 134 Spain molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 135 Spain IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 136 Enzyme suppliers in Asia
  • Table 137 Asia Pacific IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 138 Asia Pacific protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 139 Asia Pacific protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 140 Asia Pacific molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 141 Asia Pacific protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 142 Asia Pacific protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 143 Asia Pacific protease market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • Table 144 Asia Pacific IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 145 Asia Pacific infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 146 Asia Pacific IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 147 Asia Pacific molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 148 Asia Pacific IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 149 Japan IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 150 Japan protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 151 Japan protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 152 Japan molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 153 Japan protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 154 Japan protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 155 Japan protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 156 Japan IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 157 Japan infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 158 Japan IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 159 Japan molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 160 Japan IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 161 China IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 162 China protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 163 China protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 164 China molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 165 China protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 166 China protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 167 China protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 168 China IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 169 China infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 170 China IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 171 China molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 172 China IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 173 India IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 174 India protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 175 India protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 176 India molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 177 India protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 178 India protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 179 India protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 180 India IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 181 India infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 182 India IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 183 India molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 184 India IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 185 Latin America IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 186 Latin America protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 187 Latin America protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 188 Latin America molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 189 Latin America protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 190 Latin America protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 191 Latin America protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 192 Latin America IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 193 Latin America infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 194 Latin America IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 195 Latin America molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 196 Latin America IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 197 Brazil IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 198 Brazil protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 199 Brazil protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 200 Brazil molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 201 Brazil protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 202 Brazil protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 203 Brazil protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 204 Brazil IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 205 Brazil infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 206 Brazil IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 207 Brazil molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 208 Brazil IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 209 Mexico IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 210 Mexico protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 211 Mexico protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 212 Mexico molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 213 Mexico protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 214 Mexico protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 215 Mexico protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 216 Mexico IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 217 Mexico infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 218 Mexico IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 219 Mexico molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 220 Mexico IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 221 MEA IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 222 MEA protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 223 MEA protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 224 MEA molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 225 MEA protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 226 MEA protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 227 MEA protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 228 MEA IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 229 MEA infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 230 MEA IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 231 MEA molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 232 MEA IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 233 South Africa IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
  • Table 234 South Africa protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 235 South Africa protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 236 South Africa molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 237 South Africa protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
  • Table 238 South Africa protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 239 South Africa protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
  • Table 240 South Africa IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 241 South Africa infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • Table 242 South Africa IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 243 South Africa molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
  • Table 244 South Africa IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation and validation
  • Fig. 8 Market model for IVD enzymes market derived from enzymes market
  • Fig. 9 Penetration of diagnostic enzymes in the global specialty enzymes market
  • Fig. 10 Market model for IVD enzymes market derived from the IVD market
  • Fig. 11 Enzyme demand, by region
  • Fig. 12 Enzyme suppliers, by country
  • Fig. 13 Market snapshot (USD Million for 2019)
  • Fig. 14 Market trends & outlook
  • Fig. 15 Market segmentation
  • Fig. 16 Total number of COVID-19 cases, by country
  • Fig. 17 Total number of deaths due to COVID-19, by country
  • Fig. 18 Number of COVID-19 tests performed, by country
  • Fig. 19 Types of COVID-19 tests
  • Fig. 20 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 21 Porter's Five Forces Analysis
  • Fig. 22 Penetration and growth prospect mapping, 2019 (USD Million)
  • Fig. 23 IVD enzymes market drivers impact
  • Fig. 24 Enzyme-based biosensors in clinical diagnosis
  • Fig. 25 IVD enzymes market restraints impact
  • Fig. 26 IVD enzymes market opportunity impact
  • Fig. 27 IVD enzymes market challenge impact
  • Fig. 28 Segment Definition
  • Fig. 29 Commodity flow analysis modeling for enzyme types
  • Fig. 30 IVD enzymes market: Enzyme type outlook and key takeaways
  • Fig. 31 Common diagnostic enzymes
  • Fig. 32 IVD enzymes market: Enzyme type movement analysis
  • Fig. 33 Global IVD proteases market, 2016 - 2027 (USD Million)
  • Fig. 34 Segment Definition
  • Fig. 35 Global IVD proteases market for infectious diseases, 2016 - 2027 (USD Million)
  • Fig. 36 Global IVD proteases market for diabetes, 2016 - 2027 (USD Million)
  • Fig. 37 Global IVD proteases market for oncology, 2016 - 2027 (USD Million)
  • Fig. 38 Global IVD proteases market for cardiology, 2016 - 2027 (USD Million)
  • Fig. 39 Global IVD proteases market for nephrology, 2016 - 2027 (USD Million)
  • Fig. 40 Global IVD proteases market for autoimmune diseases, 2016 - 2027 (USD Million)
  • Fig. 41 Global IVD proteases market for other diseases, 2016 - 2027 (USD Million)
  • Fig. 42 Segment Definition
  • Fig. 43 Global IVD proteases market for histology assays, 2016 - 2027 (USD Million)
  • Fig. 44 Global IVD proteases market for molecular diagnostics, 2016 - 2027 (USD Million)
  • Fig. 45 Global IVD proteases market for PCR assays, 2016 - 2027 (USD Million)
  • Fig. 46 Global IVD proteases market for NGS assays, 2016 - 2027 (USD Million)
  • Fig. 47 Global IVD proteases market for other assays, 2016 - 2027 (USD Million)
  • Fig. 48 Global IVD proteases market for clinical chemistry, 2016 - 2027 (USD Million)
  • Fig. 49 Segment Definition
  • Fig. 50 Powder IVD proteases market, 2016 - 2027 (USD Million)
  • Fig. 51 Liquid IVD proteases market, 2016 - 2027 (USD Million)
  • Fig. 52 Segment Definition
  • Fig. 53 Natural IVD proteases market, 2016 - 2027 (USD Million)
  • Fig. 54 Recombinant IVD proteases market, 2016 - 2027 (USD Million)
  • Fig. 55 Segment Definition
  • Fig. 56 Global IVD proteases market for pharma & biotech companies, 2016 - 2027 (USD Million)
  • Fig. 57 Global IVD proteases market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
  • Fig. 58 Global IVD proteases market for CROs, 2016 - 2027 (USD Million)
  • Fig. 59 Global IVD proteases market for academic labs, 2016 - 2027 (USD Million)
  • Fig. 60 Diamond Taq family polymerases: Specifications
  • Fig. 61 Global IVD polymerase & transcriptase market, 2016 - 2027 (USD Million)
  • Fig. 62 Global IVD ribonuclease market, 2016 - 2027 (USD Million)
  • Fig. 63 Global other IVD enzymes market, 2016 - 2027 (USD Million)
  • Fig. 64 Segment Definition
  • Fig. 65 Penetration of therapeutic area in IVD enzymes market
  • Fig. 66 IVD enzymes market: Therapeutic area outlook and key takeaways
  • Fig. 67 IVD enzymes market: Therapeutic area movement analysis
  • Fig. 68 Global IVD enzymes market for infectious disease, 2016 - 2027 (USD Million)
  • Fig. 69 Global IVD enzymes market for COVID-19 testing, 2016 - 2027 (USD Million)
  • Fig. 70 Global IVD enzymes market for hepatitis, 2016 - 2027 (USD Million)
  • Fig. 71 Global IVD enzymes market for HIV, 2016 - 2027 (USD Million)
  • Fig. 72 Global IVD enzymes market for other infectious diseases, 2016 - 2027 (USD Million)
  • Fig. 73 Global IVD enzymes market for diabetes, 2016 - 2027 (USD Million)
  • Fig. 74 Global IVD enzymes market for oncology, 2016 - 2027 (USD Million)
  • Fig. 75 Global IVD enzymes market for cardiology, 2016 - 2027 (USD Million)
  • Fig. 76 Global IVD enzymes market for nephrology, 2016 - 2027 (USD Million)
  • Fig. 77 Global IVD enzymes market for autoimmune diseases, 2016 - 2027 (USD Million)
  • Fig. 78 Global IVD enzymes market for other diseases, 2016 - 2027 (USD Million)
  • Fig. 79 Segment Definition
  • Fig. 80 Penetration of technology type in molecular diagnostics techniques sub-type
  • Fig. 81 IVD enzymes market: Technology type outlook and key takeaways
  • Fig. 82 IVD enzymes market: Technology type movement analysis
  • Fig. 83 Utility of enzymes in pretreatment during ISH and fluorescence in situ hybridization
  • Fig. 84 Global IVD enzymes market for histology assays, 2016 - 2027 (USD Million)
  • Fig. 85 Global IVD enzymes market for molecular diagnostics, 2016 - 2027 (USD Million)
  • Fig. 86 Global IVD enzymes market for PCR assays, 2016 - 2027 (USD Million)
  • Fig. 87 Enzymes used in NGS library preparation
  • Fig. 88 Global IVD enzymes market for NGS assays, 2016 - 2027 (USD Million)
  • Fig. 89 Global IVD enzymes market for other molecular biology assays, 2016 - 2027 (USD Million)
  • Fig. 90 Global IVD enzymes market for clinical chemistry, 2016 - 2027 (USD Million)
  • Fig. 91 Segment Definition
  • Fig. 92 Penetration by end-use settings
  • Fig. 93 IVD enzymes market: End-use outlook and key takeaways
  • Fig. 94 IVD enzymes market: End-use movement analysis
  • Fig. 95 Global IVD enzymes market for pharma & biotech, 2016 - 2027 (USD Million)
  • Fig. 96 Global IVD enzymes market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
  • Fig. 97 Global IVD enzymes market for CROs, 2016 - 2027 (USD Million)
  • Fig. 98 Global IVD enzymes market for academic labs, 2016 - 2027 (USD Million)
  • Fig. 99 IVD enzymes market: Regional outlook and key takeaways
  • Fig. 100 IVD enzymes market: Regional movement analysis
  • Fig. 101 North America
  • Fig. 102 North America IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 103 U.S.
  • Fig. 104 U.S. IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 105 Canada
  • Fig. 106 Canada IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 107 Europe
  • Fig. 108 Europe IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 109 Germany
  • Fig. 110 Germany IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 111 France
  • Fig. 112 France IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 113 U.K.
  • Fig. 114 U.K. IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 115 Italy
  • Fig. 116 Italy IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 117 Spain
  • Fig. 118 Spain IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 119 Asia Pacific
  • Fig. 120 Asia Pacific IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 121 Japan
  • Fig. 122 Japan IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 123 China
  • Fig. 124 China IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 125 India
  • Fig. 126 India IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 127 Latin America
  • Fig. 128 Latin America IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 129 Brazil
  • Fig. 130 Brazil IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 131 Mexico
  • Fig. 132 Mexico IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 133 MEA
  • Fig. 134 MEA IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 135 South Africa
  • Fig. 136 South Africa IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 137 Strategy framework
  • Fig. 138 Market participation categorization